The In Vitro Characterisation of DREADD Agonist 21, a Novel Ligand for Muscarinic DREADD Receptors

Thompson, K.J., Khajehali, E., Molloy, C. , Valant, C., Bradley, S.J. , Sexton, P.M., Christopoulos, A. and Tobin, A.B. (2019) The In Vitro Characterisation of DREADD Agonist 21, a Novel Ligand for Muscarinic DREADD Receptors. British Journal of Pharmacology 176(16): 3002-3003. Selected Abstract from Pharmacology 2018, London, UK, 18-20 Dec 2018. (doi:10.1111/bph.14681)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Conference or Workshop Item
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Molloy, Mr Colin and Khajehali, Dr Elham and Thompson, Ms Karen and Tobin, Andrew and Bradley, Dr Sophie
Authors: Thompson, K.J., Khajehali, E., Molloy, C., Valant, C., Bradley, S.J., Sexton, P.M., Christopoulos, A., and Tobin, A.B.
College/School:College of Medical Veterinary and Life Sciences > Institute of Molecular Cell and Systems Biology
ISSN:0007-1188
Published Online:09 July 2019

University Staff: Request a correction | Enlighten Editors: Update this record